Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ibrutinib tyrosine-protein kinase btk small molecule Successful target TTD , drugbank , DGIDB Lymphocyte[MeSHID:D008214]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Diagnosis[MeSHID:D003933]
Waldenstrom Macroglobulinemia[MeSHID:D008258]
Fatigue[MeSHID:D005221]
Protein Biosynthesis[MeSHID:D014176]
B-Cell Lymphomas[MeSHID:D016393]
Neurological observations[MeSHID:D009461]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Lymphadenopathy[MeSHID:D000072281]
Bone Marrow[MeSHID:D001853]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Vision[MeSHID:D014785]
lymph nodes[MeSHID:D008198]
Liver[MeSHID:D008099]
Malignant lymphoma
lymphocytic
intermediate differentiation
diffuse[MeSHID:D020522]
leukemia[MeSHID:D007938]
Hemorrhage[MeSHID:D006470]
Spleen[MeSHID:D013154]
Deletion Mutation[MeSHID:D017384]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of pancreas[MeSHID:D010190]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Pancreatic carcinoma[MeSHID:C562463]
Follicular[MeSHID:D008224]		 1.34 approved inhibitor
ibrutinib tyrosine-protein kinase btk small molecule Successful target TTD , drugbank , DGIDB Lymphocyte[MeSHID:D008214]
Malignant Neoplasms[MeSHID:D009369]
Cells[MeSHID:D002477]
Diagnosis[MeSHID:D003933]
Waldenstrom Macroglobulinemia[MeSHID:D008258]
Fatigue[MeSHID:D005221]
Protein Biosynthesis[MeSHID:D014176]
B-Cell Lymphomas[MeSHID:D016393]
Neurological observations[MeSHID:D009461]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Lymphadenopathy[MeSHID:D000072281]
Bone Marrow[MeSHID:D001853]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Vision[MeSHID:D014785]
lymph nodes[MeSHID:D008198]
Liver[MeSHID:D008099]
Malignant lymphoma
lymphocytic
intermediate differentiation
diffuse[MeSHID:D020522]
leukemia[MeSHID:D007938]
Hemorrhage[MeSHID:D006470]
Spleen[MeSHID:D013154]
Deletion Mutation[MeSHID:D017384]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.34 approved inhibitor
click here to return to the previous page